NCT01853631 Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) Status RECRUITING Phase PHASE1
NCT01810120 Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT Status COMPLETED Phase PHASE1/PHASE2
NCT01796171 A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01777152 ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Status COMPLETED Phase PHASE3
NCT01760655 Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT01685008 Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL) Status COMPLETED Phase PHASE2
NCT01634217 Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT01611298 Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR Status COMPLETED Phase NA
NCT01596621 A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment Status COMPLETED Phase PHASE3
NCT01593696 Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT01527045 Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies Status COMPLETED Phase PHASE2
NCT01516619 Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia Status COMPLETED Phase PHASE2
NCT01447056 Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases Status COMPLETED Phase PHASE1
NCT01351545 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Status RECRUITING Phase N/A
NCT01344876 Phase I Study of OPB-51602 in Patients With Hematologic Malignancies Status COMPLETED Phase PHASE1